Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions
Authors:
Open Access
- 18 October 2004
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 127 (3) , 280-284
Abstract
Summary: Central nervous system (CNS) involvement is an unusual manifestation in multiple myeloma (MM). The molecular basis of CNS myeloma is poorly understood. MM is characterized by translocations involving the immunoglobulin heavy chain (IgH) locus and frequent 13q deletions. Alterations of p53 or c‐myc in MM may represent secondary changes associated with disease progression. We investigated nine patients with CNS MM using interphase fluorescence in situ hybridization (FISH) combined with immunofluorescence detection of the cytoplasmic light chain (cIg‐FISH) for the presence of above genomic aberrations. Of nine patients studied, eight cases had hemizygous p53 deletion and 4 had 13q deletions. Of the patients with 13q deletions, two had IgH translocations, one involving 4p16.3 (FGFR3), the other involving 16q23 (c‐maf). The high incidence of p53 deletions detected by cIg‐FISH in CNS myeloma may be a marker for chromosomal instability, and may be associated with metastatic features of myeloma cells.Keywords
This publication has 25 references indexed in Scilit:
- Detection of Chromosome 13q Deletions and IgH Translocations in Patients with Multiple Myeloma by FISH: Comparison with Karyotype AnalysisLeukemia & Lymphoma, 2004
- The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplantBritish Journal of Haematology, 2004
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003
- Meningeal and cerebral involvement in multiple myeloma patientsAnnals of Hematology, 2001
- Chromosome translocations in multiple myelomaOncogene, 2001
- TrueLeukemia, 1999
- Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3Nature Genetics, 1997
- Cancer progression and p53The Lancet, 1995
- p53, guardian of the genomeNature, 1992
- Rare occurrence of P53 gene mutations in multiple myelomaBritish Journal of Haematology, 1992